Shots:

• InfoBionic.Ai and Anumana have signed a joint research agreement for developing & commercializing AI-based remote technology to identify cardiac diseases using Anumana’s ECG-AI technology and InfoBionic.Ai’s MoMe ARC platform
• The collaboration aims at enhancing the ability of InfoBionic.Ai’s MoMe ARC Platform for earlier cardiac disease diagnosis in the remote patient monitoring setting. Both companies will work with the Mayo Clinic for the development
• As per the agreement, Anumana will combine its ECG-AI LEF algorithm with InfoBionic.Ai’s remote cardiac monitoring platform to identify LEF by remote cardiac activity monitoring. Both will confirm the clinical utility of the combined solution for regulatory approval. ECG-AI LEF's review across the EU is ongoing

Ref: InfoBionic.Ai | Image: InfoBionic.Ai

Related News:- Anumana Receives the US FDA’s Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com